Stapokibart Was Granted Marketing Approval From National Medical Products Administration For The Treatment Of Moderate-to-severe Atopic Dermatitis in Adults (Di venerdì 13 settembre 2024)
CHENGDU, China, Sept. 12, 2024 /PRNewswire/
Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the new drug application for Stapokibart (anti-IL-4R? monoclonal antibody, trade name: Kangyueda (???), for the indication of Moderate-to-severe Atopic Dermatitis in Adults. The Marketing Approval of Stapokibart is based on a multi-center, randomized, double-blind, placebo-controlled Phase III study, with the co-primary endpoints being the achievement of at least a 75% improvement in Eczema Area and Severity Index (EASI-75) From baseline and an Investigator's Global Assessment (IGA) score of 0 or 1 with a reduction of ?2 points From baseline at week 16.Leggi tutta la notizia su liberoquotidiano
Notizie su altre fonti
Keymed Biosciences Inc. (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has recently approved the new drug application for Stapokibart (anti-IL-4R? monoclonal antibody, trade name: Kangyueda (???), for the indication of Moderate-to-severe Atopic Dermatitis in Adults. The Marketing Approval of Stapokibart is based on a multi-center, randomized, double-blind, placebo-controlled Phase III study, with the co-primary endpoints being the achievement of at least a 75% improvement in Eczema Area and Severity Index (EASI-75) From baseline and an Investigator's Global Assessment (IGA) score of 0 or 1 with a reduction of ?2 points From baseline at week 16.Leggi tutta la notizia su liberoquotidiano
- Atlantic City Casinos Help Raise $280,000 at the American Foundation for Suicide Prevention's Walk on the Atlantic City Boardwalk - The Casino Association of New Jersey (CANJ) proudly participated in the American Foundation for Suicide Prevention's "Out of the Darkness Community Walk," on Saturday, September 7, which raised more ... lelezard
- New Survey Shows 68% of Canadian Parents Indicate their Children Face Social Challenges at School - A new study commissioned by Lactalis Canada's Cheestrings found that 68 per cent of Canadian parents indicate their child has experienced social challenges at school, with 49 per cent stating that ... lelezard
Video Stapokibart Was
Video Stapokibart Was
Facebook
Tik Tok
Twitter
Instagram
You Tube
Iscriviti
